Attempts to turn rice straw, the inedible remains of the rice crop, into a wood substitute are beginning to shed light on a host of properties that might exceed even those of humbl...
At an intergovernmental meeting in Montreal, Canada in March, participants from 114 countries voted to grant limited 'critical use exemptions' to 11 developed countries facing the ...
Personalised medicine, which promises to prevent, detect and cure diseases by linking the mechanisms and pathways of illnesses to individuals, will become a reality 'in our lifetim...
Energy company executives are raising renewed concerns over the UK's ambitious plans to cut carbon emissions one year after publication of the government's Energy White Paper.
The next major challenge facing UK researchers is to persuade society that scientific method should be at the core of scientific debate, and to diminish the influence of minority p...
Vernalis, the biotech company formed from the merger of British Biotech and the original Vernalis, has bought back the rights to its migraine drug from Irish biotech firm Elan.
A new biolabel to help biologists monitor dynamic processes in biological systems is being developed by a team at Utrecht University in The Netherlands.
Letting Nature do the hard work in preparing complex structures for microdevices is looking more likely thanks to a team of materials scientists from Ohio State University and the ...
Microfluidic devices could soon be improving the success of in vitro fertilisation, according to a team of scientists from the universities of Illinois and Wisconsin, US.
A new cage molecule with a unique 'double-propellor' structure and interesting magnetic properties has been prepared in a collaboration between universities.